Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. Thrombolytic therapy: economic considerations.
Krumholz
H M
HM
Section of Cardiology, Yale University School of Medicine, New Haven, CT 06520-8025, USA.
D017281:Cost of Illness; D003365:Costs and Cost Analysis; D019049:Developed Countries; D017850:Economics, Pharmaceutical; D005343:Fibrinolytic Agents / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000191:economics; D015425:Myocardial Reperfusion / Q000191:economics / Q000379:methods; D015912:Thrombolytic Therapy / Q000191:economics*
D005343:Fibrinolytic Agents